CAS No. |
155179-21-8 |
中文名称 |
((2S,3S,4R,5R)-4-羟基-2-(((E)-3-(4-羟基苯基)丙-2-烯酰氧)甲基)-5-((3-(4-羟基苯基)丙-2-烯酰氧)甲基)-2-(((2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(((E)-3-(4-羟基-3-甲氧基苯基)丙-2-烯酰氧)甲基)四氢-2H-吡喃-2-基)氧基)四氢呋喃-3-基)(2E)-3-(4-羟基苯基)丙-2-烯酸酯 |
英文名称 |
(2S,3S,4R,5R)-4-Hydroxy-2-((((E)-3-(4-hydroxyphenyl)acryloyl)oxy)methyl)-5-(((3-(4-hydroxyphenyl)acryloyl)oxy)methyl)-2-(((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((E)-3-(4-hydroxy-3-methoxyphenyl)acryloyl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydrofuran-3-yl (2E)-3-(4-hydroxyphenyl)acrylate |
别名 |
vanicoside B;α-D-Glucopyranoside, 1,3,6-tris-O-[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]-β-D-fructofuranosyl, 6-[(2E)-3-(4-hydroxy-3-methoxyphenyl)-2-propenoate] |
标准英文名 |
(2S,3S,4R,5R)-4-hydroxy-2-((((E)-3-(4-hydroxyphenyl)acryloyl)oxy)methyl)-5-(((3-(4-hydroxyphenyl)acryloyl)oxy)methyl)-2-(((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((E)-3-(4-hydroxy-3-methoxyphenyl)acryloyl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydrofuran-3-yl (2E)-3-(4-hydroxyphenyl)acrylate |
MDL No. |
MFCD03700744 |
分子式 |
C49H48O20 |
分子量 |
956.90
|
精确分子量 |
956.27
|
SMILES |
COC1=CC(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(COC(=O)/C=C/C4=CC=C(O)C=C4)O[C@H](COC(=O)C=CC4=CC=C(O)C=C4)[C@@H](O)[C@@H]3OC(=O)/C=C/C3=CC=C(O)C=C3)[C@H](O)[C@@H](O)[C@@H]2O)=CC=C1O |
标准SMILES |
COC1=CC(/C=C/C(=O)OC[C@H]2O[C@H](O[C@]3(COC(=O)/C=C/C4C=CC(O)=CC=4)O[C@H](COC(=O)C=CC4C=CC(O)=CC=4)[C@@H](O)[C@@H]3OC(=O)/C=C/C3C=CC(O)=CC=3)[C@H](O)[C@@H](O)[C@@H]2O)=CC=C1O |
用途 |
Vanicoside B exhibits antitumor activity by targeting cyclin-dependent kinase 8 (CDK8), blocking CDK8-mediated signaling pathways, inhibiting the expression of epithelial-mesenchymal transition proteins, and thereby inducing cell cycle arrest and apoptosis. |
InChIKey |
ALSDWGAQQGXOHC-CWAGVMQFSA-N |